National Institutes of Health logo
National Institutes of Health

Translational Transplantation Tolerance Cooperative Study Group

Funds a multi-center group translating transplant tolerance regimens toward the clinic, so grafts survive without lifelong immune-suppressing drugs.

ScheduledNational Institutes of HealthUnited States

Organ transplant recipients normally take immune-suppressing drugs for life, with all the infection and cancer risk that carries. This group exists to make that unnecessary, by getting tolerance regimens out of the lab and into people.

The goal is stated directly: facilitate clinical translation of safe and effective transplant tolerance regimens that achieve long-term graft survival without lifeโ€ฆ

Development, optimisation and evaluation of approaches to induce and maintain immune tolerance to allogeneic organ transplants, tested in translationally relevant models, aimed at clinical translation of tolerance regimens that sustain long-term graft survival without lifelong immunosuppressive drugs.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.One-off
Next deadlineiThe next date applications are due. Rolling means you can apply any time.21 May 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.$10.5M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
National Institutes of Health logo
Open

Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds a pilot trial of a behavioural sleep intervention for adolescents and young adults who have a mental health disorder or are at risk of one.

Oct'26
National Institutes of Health logo
Open

GREGoRi Data Coordination and Outreach Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.

BiotechAI
$1.3MOct'26
National Institutes of Health logo
Open

GREGoRi Innovation Projects

NIH ยท United States

Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.

BiotechAI
$3 โ€“ $500KOct'26
National Institutes of Health logo
Open

GREGoRi Technology Integration Center

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.

BiotechAI
$2.3MOct'26
National Institutes of Health logo
Open

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.

Medtech
Nov'26
National Institutes of Health logo
Open

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.

MedtechBiotech
Nov'26